H-TTNYT-OH

Ref. 3D-PP41712

Información del producto

• Nombre: H-TTNYT-OH

Descripción

Peptide H-TTNYT-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TTNYT-OH include the following: In vivo depression of lymphocyte traffic in sheep by VIP and HIV (AIDS)-related peptides TC Moore, CH Spruck, SI Said - Immunopharmacology, 1988 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0162310988900069 Chemokine Receptor Antagonists Prevent and Reverse Cofilin-Actin Rod Pathology and Protect Synapses in Cultured Rodent and Human iPSC-Derived Neurons TB Kuhn , LS Minamide, LH Tahtamouni , SA Alderfer - Biomedicines, 2024 - mdpi.comhttps://www.mdpi.com/2227-9059/12/1/93 18 A TOXIC PROTEIN FROM THE AIDS VIRUS ROSSI. BRINKWORTH, ANNELIESE F. PALMER SL RAMSDALE, PR ANDREWS - Toxins and Targets: Effects of , 1992 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=O-3DGeeWmAoC&oi=fnd&pg=PA149&dq=(%22H-TTNYT-OH%22+OR+%22H-TTNY%5ET-OH%22+OR+%22TTNYT%22+OR+%22TTNY%5ET%22)+AND+peptide&ots=YuLpeHhnYG&sig=GbWjtAD2bgGV9mLT5Sy_pK_7VCM Minimum analogue peptide sets (MAPS) for quantitative structure-activity relationships S Hellberg , L Eriksson, J Jonsson - journal of peptide , 1991 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-3011.1991.tb00756.x A Toxic Protein from the Aids Virus RI Brinkworth, AF Palmer, SL Ramsdale - Toxins and , 2022 - taylorfrancis.comhttps://www.taylorfrancis.com/chapters/edit/10.4324/9781315076911-18/toxic-protein-aids-virus-ross-brinkworth-anneliese-palmer-stephen-ramsdale-peter-andrews Vasoactive intestinal peptide 1-12: A ligand for the CD4 (T4)/human immunodeficiency virus receptor P Sacerdote, MR Ruff, CB Pert - Journal of neuroscience , 1987 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jnr.490180117 VIP1-12 Is a Ligand for the CD4/Human Immunodeficiency Virus Receptor P Sacerdote, MR Ruff, CB Pert - of the New York Academy of , 1988 - Wiley Online Libraryhttps://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1749-6632.1988.tb27010.x CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis: Relationship to vasoactive intestinal polypeptide MR Ruff, BM Martin, EI Ginns, WL Farrar, CB Pert - FEBS letters, 1987 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0014579387812656 Management of glia-mediated neuroinflammation and related patents M Kumar Jha , K Suk - Recent Patents on Inflammation & Allergy , 2014 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/iad/2014/00000008/00000002/art00004 Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxis LS Redwine , CB Pert, JD Rone, R Nixon, M Vance - Clinical , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S152166169994771X AIDS as a neuropeptide disorder: does HIV bind to a VIP receptor? JM Hill, AI Kook, A Harris - : 1 and 2 Proceedings of the XVIth CINP , 1990 - Springerhttps://link.springer.com/chapter/10.1007/978-3-642-74034-3_72 Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen J Schuman, AP Campbell, RR Koganty - Journal of peptide , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1399-3011.2003.00031.x Impact of point mutations on the structure and thermal stability of ribonuclease T1 in aqueous solution probed by Fourier transform infrared spectroscopy H Fabian, C Schultz, J Backmann , U Hahn - Biochemistry, 1994 - ACS Publicationshttps://pubs.acs.org/doi/pdf/10.1021/bi00201a021 A new vasoactive intestinal peptide antagonist discriminates VIP receptors on guinea pig trachea and human neuroblastoma cells F Leroux, JF Goossens, N Pommery, JP Henichart - Regulatory peptides, 1994 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0167011594900442 The role of microglial cells on neuroinflammation: possible therapeutic applications DM de Oliveira, N OS Camara - Recent Patents on , 2012 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/rpgm/2012/00000002/00000003/art00005 gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systems DE Brenneman, SK McCune, RF Mervis - Advances in , 1994 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0960542806802524 Peptide T sequences prevent neuronal cell death produced by the envelope protein (gp 120) of the human immunodeficiency virus DE Brenneman, JM Buzy, MR Ruff - Drug development , 1988 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/ddr.430150403 Peptide Intervention in Neuronal Death Caused by the HIV External Envelope Protein: Clinical Implications DE Brenneman - Neuropsychopharmacology: 1 and 2 Proceedings of , 1990 - Springerhttps://link.springer.com/chapter/10.1007/978-3-642-74034-3_71 Peptide T revisited: conformational mimicry of epitopes of anti-HIV proteins D Picone , A Rivieccio, O Crescenzi - Journal of Peptide , 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.320 Tritiated D-ala1-peptide T binding: A pharmacologic basis for the design of drugs which inhibit HIV receptor binding CC Smith, PL Hallberg, P Sacerdote - Drug development , 1988 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.430150404 SHORT COMMUNICATION HYPOTENSIVE EFFECTS OF PEPTIDE T IN CONSCIOUS RATS C Wen, DT Liu, M Li, J Michaelis - Clinical and , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1440-1681.1997.tb02120.x

• Marca: Biosynth